Imipramine HCl ER capsules bulk supplier for pharma manufacturers

Imipramine Hcl Er Capsules Suppliers & Bulk Manufacturers

Available Forms: Capsules (Extended-Release)

Available Strengths: 75 mg, 100 mg, 125 mg, 150 mg

Reference Brands: Tofranil-PM® (US)

Imipramine is a tricyclic antidepressant (TCA) that works by inhibiting the reuptake of norepinephrine and serotonin, increasing their availability in the synaptic cleft and enhancing mood regulation. It also has mild anticholinergic and sedative properties. The extended-release (ER) formulation provides sustained therapeutic levels over time. Imipramine ER capsules are used to treat major depressive disorder and nocturnal enuresis (bedwetting) in children aged 6 and older, especially when other treatments are ineffective.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Imipramine HCl ER capsules are FDA-approved in the United States for the treatment of depression and childhood enuresis (bedwetting). As a tricyclic antidepressant (TCA), it requires CNS safety labeling, including warnings for suicidal thoughts in young adults and children. ER formulations must meet strict modified-release manufacturing and bioequivalence standards for generics. In the European Union, imipramine is approved under national authorizations for similar psychiatric and urological indications. EU regulatory requirements include GMP-compliant production, Risk Management Plans (RMPs), and pharmacovigilance obligations. For dossier-ready supply and global sourcing of Imipramine HCl ER capsules, visit Pharmatradz.com.

Imipramine Hcl Er Capsules — third party manufacturing & bulk supply

Imipramine Hcl Er Capsules is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Imipramine Hcl Er Capsules is supplied as Capsules (Extended-Release) — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Imipramine Hcl Er Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Imipramine Hcl Er Capsules →

Back to Listing

Frequently Asked Questions

Imipramine HCl ER capsules is listed as Capsules (Extended-Release) in 75 mg, 100 mg, 125 mg, 150 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Imipramine HCl ER capsules is referenced against Tofranil-PM® (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.